Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1085 | 1130 | 1263 | 1312 | 1758 |
Fund Return | 4.18% | 8.5% | 13.04% | 8.09% | 5.58% | 5.8% |
Place in category | 19 | 17 | 5 | 194 | 175 | 25 |
% in Category | 11 | 8 | 4 | 60 | 65 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI C | 6.49B | 2.87 | 4.23 | 6.36 | ||
Acatis Gane Value Event Fonds UI A | 6.49B | 3.66 | 3.47 | 6.32 | ||
Acatis Gane Value Event Fonds UI B | 6.49B | 3.85 | 3.91 | 6.76 | ||
ACATIS Datini Valueflex Fonds B | 808.72M | 2.55 | -0.96 | 10.84 | ||
ACATIS Datini Valueflex Fonds A | 808.72M | 2.84 | -0.13 | 11.65 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MEAG EuroInvest A | 923.44M | 2.58 | 6.12 | 6.05 | ||
MEAG EuroInvest I | 27.86M | 2.73 | 7.07 | 7.00 | ||
First Private Europa Aktien ULM A | 214.77M | 1.72 | 7.58 | 3.42 | ||
First Private Europa Aktien ULM B | 829.16K | 7.37 | 3.94 | 4.68 | ||
Allianz Vermogensbildung Europa A E | 194.26M | 0.55 | 5.99 | 4.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.90 | 927.3 | +1.13% | |
Roche Holding Participation | CH0012032048 | 3.88 | 231.00 | +1.18% | |
Novartis | CH0012005267 | 3.16 | 92.96 | +1.90% | |
Relx | GB00B2B0DG97 | 2.65 | 3,416.00 | +0.44% | |
Stellantis NV | NL00150001Q9 | 2.56 | 20.200 | -1.34% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review